Business
Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments
Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptomsZORYVE® (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely formulated to treat the itching, redness, and flaking of seborrheic dermatitis anywhere it appears, including hair-bearing areas10 million Americans live with seborrheic dermatitis, a chronic inflammatory skin disease that occurs most often on areas with oil-producing glands, including the face an
About this update from Arcutis Biotherapeutics, Inc.
[{"type":"image","alt":"Arcutis Biotherapeutics, Inc.","displaySize":"","headline":null,"caption":"Arcutis Biotherapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":54,"url":"https://media.zenfs.com/en/globenewswire.com/7ec1ad75d1b30c39742ed46c38e50fa3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZXyX7hU4QA6ZJJZzELXH5w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/7ec1ad75d1b30c39742ed46c38e50fa3","width":300,"height":54}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptoms","length":108,"tagName":"p"}]},{"val":[{"type":"text","content":"ZORYVE® (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely formulated to treat the itching, redness, and flaking of seborrheic dermatitis anywhere it appears, including hair-bearing areas","length":222,"tagName":"p"}]},{"val":[{"type":"text","content":"10 million Americans live with seborrheic dermatitis, a chronic inflammatory skin disease that occurs most often on areas with oil-producing glands, including the face and scalp","length":177,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":507,"olType":false},{"type":"text","content":"WESTLAKE VILLAGE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that six-time PGA Tour winner Max Homa has joined the company’s Free to Be Me awareness campaign to help encourage the millions of Americans living with seborrheic dermatitis (seb derm) to speak with their healthcare providers about long-term treatment options.","length":506,"tagName":"p"},{"type":"text","content":"Like many people with seb derm, Max Homa spent years trying to understand what was happening to his skin. He often scrolled through the internet trying to self-diagnose what was causing his dry, flaky, and itchy face and scalp. He also tried countless over-the-counter treatments, but nothing helped his symptoms or provided long-term relief. By joining the Free to Be Me campaign, Max hopes that his story will encourage people to speak with their doctor to identif...